P-58. Quantifying the impact of introducing a new adult-focused PCV in the United States
Sign Up to like & getrecommendations! Published in 2025 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofae631.265
Abstract: Abstract Background In the United States, pneumococcal conjugate vaccines (PCVs) were first recommended for use in children in 2000, and approximately 82% currently receive the full 3+1 schedule. As of May 2024, adults aged 65… read more here.
Keywords: united states; pcv20; phd merck; merck inc ... See more keywords